SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC to support a new
At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988.
The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,
The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and investment on
MAC Clinical Research featured in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills.
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has
MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced statistically significant results on key efficacy endpoints in severe ED patients after a single administration of IPED2015. Moreover, no observations of critical adverse events were recorded.
Dr John Connell (Chief Scientific Officer) and MAC’s wider team of clinical development experts attended this years Clinical Trials Europe conference in
Make a bright future for yourself with a rewarding career at MAC Clinical Research
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
